社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Vincxie
IP属地：未知
+关注
帖子 · 52
帖子 · 52
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Vincxie
Vincxie
·
2021-12-02
Will chiong
Grab stock Skyrocketed 32% in premarket trading<blockquote>Grab股价在盘前交易中飙升32%</blockquote>
Grab stock Skyrocketed 32% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food
Grab stock Skyrocketed 32% in premarket trading<blockquote>Grab股价在盘前交易中飙升32%</blockquote>
看
1,600
回复
评论
点赞
2
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-28
Like 👍
US IPO Week Ahead: December kicks off with a 1 IPO week<blockquote>美国IPO周：12月以1周IPO开始</blockquote>
The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise
US IPO Week Ahead: December kicks off with a 1 IPO week<blockquote>美国IPO周：12月以1周IPO开始</blockquote>
看
2,151
回复
1
点赞
8
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-15
Swee
非常抱歉，此主贴已删除
看
2,117
回复
1
点赞
5
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-15
Liked
非常抱歉，此主贴已删除
看
2,691
回复
评论
点赞
1
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-14
Gd
US IPO Week Ahead: The IPO market settles down with 7 IPOs as the holiday week approaches<blockquote>美国IPO一周：随着假期周的临近，IPO市场稳定下来，有7家IPO</blockquote>
The IPO market is expected to pump the brakes ahead of the Thanksgiving holiday with seven IPOs sche
US IPO Week Ahead: The IPO market settles down with 7 IPOs as the holiday week approaches<blockquote>美国IPO一周：随着假期周的临近，IPO市场稳定下来，有7家IPO</blockquote>
看
2,379
回复
评论
点赞
1
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-09
$Phunware, Inc.(PHUN)$
I Wana be alone now… need much to ave down .
看
1,561
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-07
$Phunware, Inc.(PHUN)$
等你等到我心痛
看
1,520
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-06
$Phunware, Inc.(PHUN)$
欲哭无泪
看
3,126
回复
评论
点赞
1
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-06
$Aterian Inc.(ATER)$
遥不可及吗？
看
1,564
回复
评论
点赞
4
编组 21备份 2
分享
举报
Vincxie
Vincxie
·
2021-11-06
Ok
Will Pfizer Outgun Merck With Oral COVID-19 Pill?<blockquote>辉瑞口服新冠肺炎药丸会超过默克吗？</blockquote>
Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy
Will Pfizer Outgun Merck With Oral COVID-19 Pill?<blockquote>辉瑞口服新冠肺炎药丸会超过默克吗？</blockquote>
看
1,494
回复
评论
点赞
4
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3580183572660250","uuid":"3580183572660250","gmtCreate":1617089744183,"gmtModify":1617612924767,"name":"Vincxie","pinyin":"vincxie","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":187,"tweetSize":52,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"80.79%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.74%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":603464620,"gmtCreate":1638441417160,"gmtModify":1638442187846,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"Will chiong ","listText":"Will chiong ","text":"Will chiong","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603464620","repostId":"1158072179","repostType":4,"repost":{"id":"1158072179","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638436880,"share":"https://www.laohu8.com/m/news/1158072179?lang=zh_CN&edition=full","pubTime":"2021-12-02 17:21","market":"us","language":"en","title":"Grab stock Skyrocketed 32% in premarket trading<blockquote>Grab股价在盘前交易中飙升32%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158072179","media":"Tiger Newspress","summary":"Grab stock Skyrocketed 32% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food","content":"<p>Grab stock Skyrocketed 32% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food delivery firm,lists on Nasdaq on Thursday following its $40 billion merger with special-purpose acquisition company (SPAC) Altimeter Growth Corp(AGC.O).</p><p><blockquote>Grab股价在盘前交易中飙升32%。东南亚最大的网约车和食品配送公司Grab在以400亿美元与特殊目的收购公司(SPAC)Altimeter Growth Corp(AGC.O)合并后，于周四在纳斯达克上市。</blockquote></p><p> The deal is the world's biggest ever by a blank-check company and the biggest U.S. listing by a Southeast Asian firm.</p><p><blockquote>这笔交易是全球有史以来最大的空白支票公司交易，也是东南亚公司在美国最大的上市交易。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/755034d12dd8b016df0369d94758007a\" tg-width=\"850\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab stock Skyrocketed 32% in premarket trading<blockquote>Grab股价在盘前交易中飙升32%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab stock Skyrocketed 32% in premarket trading<blockquote>Grab股价在盘前交易中飙升32%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-02 17:21</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Grab stock Skyrocketed 32% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food delivery firm,lists on Nasdaq on Thursday following its $40 billion merger with special-purpose acquisition company (SPAC) Altimeter Growth Corp(AGC.O).</p><p><blockquote>Grab股价在盘前交易中飙升32%。东南亚最大的网约车和食品配送公司Grab在以400亿美元与特殊目的收购公司(SPAC)Altimeter Growth Corp(AGC.O)合并后，于周四在纳斯达克上市。</blockquote></p><p> The deal is the world's biggest ever by a blank-check company and the biggest U.S. listing by a Southeast Asian firm.</p><p><blockquote>这笔交易是全球有史以来最大的空白支票公司交易，也是东南亚公司在美国最大的上市交易。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/755034d12dd8b016df0369d94758007a\" tg-width=\"850\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158072179","content_text":"Grab stock Skyrocketed 32% in premarket trading.Grab, Southeast Asia's biggest ride-hailing and food delivery firm,lists on Nasdaq on Thursday following its $40 billion merger with special-purpose acquisition company (SPAC) Altimeter Growth Corp(AGC.O).\nThe deal is the world's biggest ever by a blank-check company and the biggest U.S. listing by a Southeast Asian firm.","news_type":1,"symbols_score_info":{"GRAB":0.9}},"isVote":1,"tweetType":1,"viewCount":1600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600335638,"gmtCreate":1638065605121,"gmtModify":1638065605248,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"Like 👍 ","listText":"Like 👍 ","text":"Like 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600335638","repostId":"1153242523","repostType":4,"repost":{"id":"1153242523","kind":"news","pubTimestamp":1638063498,"share":"https://www.laohu8.com/m/news/1153242523?lang=zh_CN&edition=full","pubTime":"2021-11-28 09:38","market":"us","language":"en","title":"US IPO Week Ahead: December kicks off with a 1 IPO week<blockquote>美国IPO周：12月以1周IPO开始</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1153242523","media":"Renaissance Capital","summary":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise ","content":"<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p><p><blockquote>假期周后，美国IPO市场正在喘口气，12月第一周只有一宗IPO计划筹集3000万美元。</blockquote></p><p> While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider <b>Coforge</b> (CFRG.RC), cloud infrastructure platform <b>HashiCorp</b> (HCP), luxury fashion e-tailer <b>Rue Gilt Group</b> (RGG), rugged apparel brand <b>5.11 ABR</b>(VXI), and Florida-based insurer <b>TypTapInsurance Group</b> (TYTP).</p><p><blockquote>虽然目前日历平静，但有几家IPO有资格在周一启动，其中包括印度IT服务提供商<b>科福吉</b>（CFRG.RC），云基础设施平台<b>哈希公司</b>(HCP)，奢侈时尚电子零售商<b>Rue Gilt集团</b>(RGG)，坚固的服装品牌<b>5.11 4月</b>(VXI)和总部位于佛罗里达州的保险公司<b>TypTap保险集团</b>（TYTP）。</blockquote></p><p> Phase 1-ready biotech <b>Nuvectis Pharma</b> (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p><p><blockquote>第一阶段就绪生物技术<b>Nuvectis Pharma</b>(NVCT)计划以1.6亿美元的市值筹集3000万美元。该公司最初专注于开发创新精准药物，用于治疗肿瘤学中严重未满足的医疗需求。Nuvectis目前正在开发两种临床前候选药物，其主要候选药物预计将在2021年第四季度开始1期试验。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p><p><blockquote>预计未来一周将有12家公司接受Street research，最多有4家公司的禁售期将到期。要获得街头研究和锁定日期，请注册免费试用IPO Pro。</blockquote></p><p> <b>IPO Market Snapshot</b></p><p><blockquote><b>IPO市场快照</b></blockquote></p><p> The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p><p><blockquote>文艺复兴IPO指数是新上市公司的市值加权篮子。截至2021年11月24日，文艺复兴IPO指数今年迄今下跌1.1%，而标普500上涨25.2%。Renaissance Capital的IPO ETF（纽约证券交易所股票代码：IPO）跟踪该指数，持有的顶级ETF包括Snowflake（SNOW）和Moderna（MRNA）。Renaissance International IPO指数今年迄今下跌22.4%，而ACWX指数上涨7.4%。Renaissance Capital的国际IPO ETF（纽约证券交易所股票代码：IPOS）跟踪该指数，持有最多的ETF包括美团-W大众点评和软银。</blockquote></p><p></p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: December kicks off with a 1 IPO week<blockquote>美国IPO周：12月以1周IPO开始</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: December kicks off with a 1 IPO week<blockquote>美国IPO周：12月以1周IPO开始</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Renaissance Capital</strong><span class=\"h-time small\">2021-11-28 09:38</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.</p><p><blockquote>假期周后，美国IPO市场正在喘口气，12月第一周只有一宗IPO计划筹集3000万美元。</blockquote></p><p> While the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider <b>Coforge</b> (CFRG.RC), cloud infrastructure platform <b>HashiCorp</b> (HCP), luxury fashion e-tailer <b>Rue Gilt Group</b> (RGG), rugged apparel brand <b>5.11 ABR</b>(VXI), and Florida-based insurer <b>TypTapInsurance Group</b> (TYTP).</p><p><blockquote>虽然目前日历平静，但有几家IPO有资格在周一启动，其中包括印度IT服务提供商<b>科福吉</b>（CFRG.RC），云基础设施平台<b>哈希公司</b>(HCP)，奢侈时尚电子零售商<b>Rue Gilt集团</b>(RGG)，坚固的服装品牌<b>5.11 4月</b>(VXI)和总部位于佛罗里达州的保险公司<b>TypTap保险集团</b>（TYTP）。</blockquote></p><p> Phase 1-ready biotech <b>Nuvectis Pharma</b> (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.</p><p><blockquote>第一阶段就绪生物技术<b>Nuvectis Pharma</b>(NVCT)计划以1.6亿美元的市值筹集3000万美元。该公司最初专注于开发创新精准药物，用于治疗肿瘤学中严重未满足的医疗需求。Nuvectis目前正在开发两种临床前候选药物，其主要候选药物预计将在2021年第四季度开始1期试验。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ebedc817c5c3858bec4f16c6152bfce8\" tg-width=\"936\" tg-height=\"163\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Street research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.</p><p><blockquote>预计未来一周将有12家公司接受Street research，最多有4家公司的禁售期将到期。要获得街头研究和锁定日期，请注册免费试用IPO Pro。</blockquote></p><p> <b>IPO Market Snapshot</b></p><p><blockquote><b>IPO市场快照</b></blockquote></p><p> The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p><p><blockquote>文艺复兴IPO指数是新上市公司的市值加权篮子。截至2021年11月24日，文艺复兴IPO指数今年迄今下跌1.1%，而标普500上涨25.2%。Renaissance Capital的IPO ETF（纽约证券交易所股票代码：IPO）跟踪该指数，持有的顶级ETF包括Snowflake（SNOW）和Moderna（MRNA）。Renaissance International IPO指数今年迄今下跌22.4%，而ACWX指数上涨7.4%。Renaissance Capital的国际IPO ETF（纽约证券交易所股票代码：IPOS）跟踪该指数，持有最多的ETF包括美团-W大众点评和软银。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week\">Renaissance Capital</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVCT":"Nuvectis Pharma, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89065/US-IPO-Week-Ahead-December-kicks-off-with-a-1-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153242523","content_text":"The US IPO market is taking a breather after the holiday week, with just one IPO scheduled to raise $30 million in the first week of December.\nWhile the calendar is quiet at the moment, several IPOs are eligible to launch on Monday, including Indian IT services provider Coforge (CFRG.RC), cloud infrastructure platform HashiCorp (HCP), luxury fashion e-tailer Rue Gilt Group (RGG), rugged apparel brand 5.11 ABR(VXI), and Florida-based insurer TypTapInsurance Group (TYTP).\nPhase 1-ready biotech Nuvectis Pharma (NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently developing two preclinical candidates, with its lead candidate expected to begin a Phase 1 trial in the 4Q21.\n\nStreet research is expected to 12 companies in the week ahead, and lock-up periods will be expiring for up to four companies. For access to Street research and lock-up dates,sign up for a free trial of IPO Pro.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/24/2021, the Renaissance IPO Index was down 1.1% year-to-date, while the S&P 500 was up 25.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 7.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1,"symbols_score_info":{"NVCT":0.9}},"isVote":1,"tweetType":1,"viewCount":2151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873667148,"gmtCreate":1636939080070,"gmtModify":1636939080134,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"Swee","listText":"Swee","text":"Swee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873667148","repostId":"2183536049","repostType":4,"isVote":1,"tweetType":1,"viewCount":2117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873664632,"gmtCreate":1636939049295,"gmtModify":1636939049363,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"Liked ","listText":"Liked ","text":"Liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873664632","repostId":"1187261391","repostType":2,"isVote":1,"tweetType":1,"viewCount":2691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873972663,"gmtCreate":1636852623372,"gmtModify":1636853415608,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873972663","repostId":"1186112608","repostType":2,"repost":{"id":"1186112608","kind":"news","pubTimestamp":1636849602,"share":"https://www.laohu8.com/m/news/1186112608?lang=zh_CN&edition=full","pubTime":"2021-11-14 08:26","market":"us","language":"en","title":"US IPO Week Ahead: The IPO market settles down with 7 IPOs as the holiday week approaches<blockquote>美国IPO一周：随着假期周的临近，IPO市场稳定下来，有7家IPO</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1186112608","media":"Renaissance Capital","summary":"The IPO market is expected to pump the brakes ahead of the Thanksgiving holiday with seven IPOs sche","content":"<p>The IPO market is expected to pump the brakes ahead of the Thanksgiving holiday with seven IPOs scheduled to raise $1.9 billion in the week ahead.</p><p><blockquote>预计IPO市场将在感恩节假期前踩刹车，未来一周将有七起IPO筹集19亿美元。</blockquote></p><p> Childcare provider <b>KinderCare Learning Companies</b>(KLC) plans to raise $503 million at a $2.7 billion market cap. The company serves children from 6 weeks to 12 years of age through 1,480 early childhood education centers and 650 before- and after-school sites across 40 states and Washington DC. While KinderCare is a leader in the early childhood education market, its business been significantly disrupted by the pandemic.</p><p><blockquote>托儿服务提供者<b>KinderCare学习公司</b>(KLC)计划以27亿美元的市值筹集5.03亿美元。该公司通过遍布40个州和华盛顿州DC的1,480个幼儿教育中心和650个学前和课后场所为6周至12岁的儿童提供服务。虽然KinderCare是幼儿教育市场的领导者，但其业务受到了疫情的严重干扰。</blockquote></p><p> <b>Braze</b>(BRZE) plans to raise $460 million at a $5.9 billion market cap. Founder-led Braze provides a customer engagement platform used by businesses to improve their marketing. Unprofitable with strong growth, Braze serves over 1,100 clients with net revenue retention of 120%+ as of 7/31/21.</p><p><blockquote><b>钎焊</b>(BRZE)计划以59亿美元的市值筹集4.6亿美元。创始人领导的Braze提供了一个客户参与平台，供企业用来改善其营销。截至2011年7月31日，Braze为1,100多家客户提供服务，净收入保留率为120%以上，但增长强劲。</blockquote></p><p> Fast casual salad chain <b>Sweetgreen</b>(SG) plans to raise $300 million at a $2.9 billion market cap. Sweetgreen owned and operated 140 restaurants in 13 states and Washington DC as of 9/26/21. The company has a strong digital presence and plans double its store count in the next three to five years, though it has yet to achieve profitability.</p><p><blockquote>快速休闲沙拉连锁店<b>甜绿</b>(SG)计划以29亿美元的市值筹集3亿美元。截至2011年9月26日，Sweetgreen在13个州和华盛顿州DC拥有并经营140家餐厅。该公司拥有强大的数字业务，并计划在未来三到五年内将其商店数量增加一倍，尽管尚未实现盈利。</blockquote></p><p> <b>UserTesting</b>(USER) plans to raise $227 million at a $2.6 billion market cap. The company provides a video-first customer feedback platform for enterprises, providing richer, more contextualized insights by capturing various human signals. Its customers include a diverse base of more than 2,100 enterprises, with strong net dollar-based retention. However, it remains unprofitable due to high S&M spend.</p><p><blockquote><b>用户测试</b>（用户）计划以26亿美元的市值筹集2.27亿美元。该公司为企业提供视频优先的客户反馈平台，通过捕捉各种人类信号提供更丰富、更情境化的见解。其客户包括2,100多家企业，以美元计算的净保留率很高。然而，由于S&M的高支出，它仍然无利可图。</blockquote></p><p> Australia’s <b>Iris Energy</b>(IREN), a Bitcoin mining company primarily powered by renewable energy, plans to raise $215 million at a $1.4 billion market cap. Iris acquired its first site in British Columbia in January 2021, which has approximately 30 MW of capacity and operating hashrate capacity of 0.7EH/s. The company is dependent on the Bitcoin market, and while prices have risen near all-time highs, it remains highly volatile.</p><p><blockquote>澳大利亚的<b>虹膜能量</b>(IREN)是一家主要由可再生能源供电的比特币矿业公司，计划以14亿美元的市值筹集2.15亿美元。Iris于2021年1月收购了其在不列颠哥伦比亚省的第一个站点，该站点的容量约为30兆瓦，运行算力容量为0.7 EH/s。该公司依赖比特币市场，尽管价格已升至接近历史高点，但仍高度波动。</blockquote></p><p> Germany-based <b>Sono Group</b>(SEV) plans to raise $150 million at a $1.1 billion market cap. The company is developing what it believes is disruptive solar technology, as well as a solar and battery powered vehicle. Despite already accepting 16,000 pre-orders worth $390 million in net sales, it is not expected to reach commercialization until 2023, and will remain highly unprofitable for years.</p><p><blockquote>总部位于德国<b>索诺集团</b>(SEV)计划以11亿美元的市值筹集1.5亿美元。该公司正在开发它认为是颠覆性的太阳能技术，以及太阳能和电池驱动的汽车。尽管已经接受了16,000份预购订单，净销售额为3.9亿美元，但预计要到2023年才能实现商业化，并且多年来仍将高度无利可图。</blockquote></p><p> Canadian gold exploration company <b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. The company currently has interests in four gold exploration properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p><p><blockquote>加拿大黄金勘探公司<b>奥斯汀·戈尔德</b>(AUST)计划以6400万美元的市值筹集1500万美元。该公司目前拥有位于内华达州的四个黄金勘探矿区的权益，目前只有一个矿区被认为是重要的。迄今为止，奥斯汀黄金尚未产生任何营业收入。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c7e8c1cff28007ea86b0a909cd54cc1f\" tg-width=\"1129\" tg-height=\"683\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>IPO Market Snapshot</b></p><p><blockquote><b>IPO市场快照</b></blockquote></p><p> The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/11/2021, the Renaissance IPO Index was up 3.6% year-to-date, while the S&P 500 was up 23.8%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Uber Technologies (UBER). The Renaissance International IPO Index was down 18.7% year-to-date, while the ACWX was up 8.7%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p><p><blockquote>文艺复兴IPO指数是新上市公司的市值加权篮子。截至2021年11月11日，文艺复兴IPO指数今年迄今上涨了3.6%，而标普500上涨了23.8%。Renaissance Capital的IPO ETF（纽约证券交易所股票代码：IPO）跟踪该指数，持有的顶级ETF包括Snowflake（SNOW）和Uber Technologies（UBER）。Renaissance International IPO指数今年迄今下跌18.7%，而ACWX指数上涨8.7%。Renaissance Capital的国际IPO ETF（纽约证券交易所股票代码：IPOS）跟踪该指数，持有最多的ETF包括美团-W大众点评和软银。</blockquote></p><p></p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The IPO market settles down with 7 IPOs as the holiday week approaches<blockquote>美国IPO一周：随着假期周的临近，IPO市场稳定下来，有7家IPO</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The IPO market settles down with 7 IPOs as the holiday week approaches<blockquote>美国IPO一周：随着假期周的临近，IPO市场稳定下来，有7家IPO</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Renaissance Capital</strong><span class=\"h-time small\">2021-11-14 08:26</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The IPO market is expected to pump the brakes ahead of the Thanksgiving holiday with seven IPOs scheduled to raise $1.9 billion in the week ahead.</p><p><blockquote>预计IPO市场将在感恩节假期前踩刹车，未来一周将有七起IPO筹集19亿美元。</blockquote></p><p> Childcare provider <b>KinderCare Learning Companies</b>(KLC) plans to raise $503 million at a $2.7 billion market cap. The company serves children from 6 weeks to 12 years of age through 1,480 early childhood education centers and 650 before- and after-school sites across 40 states and Washington DC. While KinderCare is a leader in the early childhood education market, its business been significantly disrupted by the pandemic.</p><p><blockquote>托儿服务提供者<b>KinderCare学习公司</b>(KLC)计划以27亿美元的市值筹集5.03亿美元。该公司通过遍布40个州和华盛顿州DC的1,480个幼儿教育中心和650个学前和课后场所为6周至12岁的儿童提供服务。虽然KinderCare是幼儿教育市场的领导者，但其业务受到了疫情的严重干扰。</blockquote></p><p> <b>Braze</b>(BRZE) plans to raise $460 million at a $5.9 billion market cap. Founder-led Braze provides a customer engagement platform used by businesses to improve their marketing. Unprofitable with strong growth, Braze serves over 1,100 clients with net revenue retention of 120%+ as of 7/31/21.</p><p><blockquote><b>钎焊</b>(BRZE)计划以59亿美元的市值筹集4.6亿美元。创始人领导的Braze提供了一个客户参与平台，供企业用来改善其营销。截至2011年7月31日，Braze为1,100多家客户提供服务，净收入保留率为120%以上，但增长强劲。</blockquote></p><p> Fast casual salad chain <b>Sweetgreen</b>(SG) plans to raise $300 million at a $2.9 billion market cap. Sweetgreen owned and operated 140 restaurants in 13 states and Washington DC as of 9/26/21. The company has a strong digital presence and plans double its store count in the next three to five years, though it has yet to achieve profitability.</p><p><blockquote>快速休闲沙拉连锁店<b>甜绿</b>(SG)计划以29亿美元的市值筹集3亿美元。截至2011年9月26日，Sweetgreen在13个州和华盛顿州DC拥有并经营140家餐厅。该公司拥有强大的数字业务，并计划在未来三到五年内将其商店数量增加一倍，尽管尚未实现盈利。</blockquote></p><p> <b>UserTesting</b>(USER) plans to raise $227 million at a $2.6 billion market cap. The company provides a video-first customer feedback platform for enterprises, providing richer, more contextualized insights by capturing various human signals. Its customers include a diverse base of more than 2,100 enterprises, with strong net dollar-based retention. However, it remains unprofitable due to high S&M spend.</p><p><blockquote><b>用户测试</b>（用户）计划以26亿美元的市值筹集2.27亿美元。该公司为企业提供视频优先的客户反馈平台，通过捕捉各种人类信号提供更丰富、更情境化的见解。其客户包括2,100多家企业，以美元计算的净保留率很高。然而，由于S&M的高支出，它仍然无利可图。</blockquote></p><p> Australia’s <b>Iris Energy</b>(IREN), a Bitcoin mining company primarily powered by renewable energy, plans to raise $215 million at a $1.4 billion market cap. Iris acquired its first site in British Columbia in January 2021, which has approximately 30 MW of capacity and operating hashrate capacity of 0.7EH/s. The company is dependent on the Bitcoin market, and while prices have risen near all-time highs, it remains highly volatile.</p><p><blockquote>澳大利亚的<b>虹膜能量</b>(IREN)是一家主要由可再生能源供电的比特币矿业公司，计划以14亿美元的市值筹集2.15亿美元。Iris于2021年1月收购了其在不列颠哥伦比亚省的第一个站点，该站点的容量约为30兆瓦，运行算力容量为0.7 EH/s。该公司依赖比特币市场，尽管价格已升至接近历史高点，但仍高度波动。</blockquote></p><p> Germany-based <b>Sono Group</b>(SEV) plans to raise $150 million at a $1.1 billion market cap. The company is developing what it believes is disruptive solar technology, as well as a solar and battery powered vehicle. Despite already accepting 16,000 pre-orders worth $390 million in net sales, it is not expected to reach commercialization until 2023, and will remain highly unprofitable for years.</p><p><blockquote>总部位于德国<b>索诺集团</b>(SEV)计划以11亿美元的市值筹集1.5亿美元。该公司正在开发它认为是颠覆性的太阳能技术，以及太阳能和电池驱动的汽车。尽管已经接受了16,000份预购订单，净销售额为3.9亿美元，但预计要到2023年才能实现商业化，并且多年来仍将高度无利可图。</blockquote></p><p> Canadian gold exploration company <b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. The company currently has interests in four gold exploration properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p><p><blockquote>加拿大黄金勘探公司<b>奥斯汀·戈尔德</b>(AUST)计划以6400万美元的市值筹集1500万美元。该公司目前拥有位于内华达州的四个黄金勘探矿区的权益，目前只有一个矿区被认为是重要的。迄今为止，奥斯汀黄金尚未产生任何营业收入。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c7e8c1cff28007ea86b0a909cd54cc1f\" tg-width=\"1129\" tg-height=\"683\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <b>IPO Market Snapshot</b></p><p><blockquote><b>IPO市场快照</b></blockquote></p><p> The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/11/2021, the Renaissance IPO Index was up 3.6% year-to-date, while the S&P 500 was up 23.8%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Uber Technologies (UBER). The Renaissance International IPO Index was down 18.7% year-to-date, while the ACWX was up 8.7%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p><p><blockquote>文艺复兴IPO指数是新上市公司的市值加权篮子。截至2021年11月11日，文艺复兴IPO指数今年迄今上涨了3.6%，而标普500上涨了23.8%。Renaissance Capital的IPO ETF（纽约证券交易所股票代码：IPO）跟踪该指数，持有的顶级ETF包括Snowflake（SNOW）和Uber Technologies（UBER）。Renaissance International IPO指数今年迄今下跌18.7%，而ACWX指数上涨8.7%。Renaissance Capital的国际IPO ETF（纽约证券交易所股票代码：IPOS）跟踪该指数，持有最多的ETF包括美团-W大众点评和软银。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.renaissancecapital.com/IPO-Center/News/88589/US-IPO-Week-Ahead-The-IPO-market-settles-down-with-7-IPOs-as-the-holiday-we\">Renaissance Capital</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRZE":"Braze, Inc.","KLC":"KinderCare Learning Companies, Inc. (Revived IPO)",".IXIC":"NASDAQ Composite","AUST.AU":"BETASHARES MANAGED RISK AUST","SG":"Sweetgreen, Inc.","IREN":"IREN Ltd",".SPX":"S&P 500 Index","USER":"UserTesting, INC.",".DJI":"道琼斯","SEV":"Aptera Motors"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/88589/US-IPO-Week-Ahead-The-IPO-market-settles-down-with-7-IPOs-as-the-holiday-we","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186112608","content_text":"The IPO market is expected to pump the brakes ahead of the Thanksgiving holiday with seven IPOs scheduled to raise $1.9 billion in the week ahead.\nChildcare provider KinderCare Learning Companies(KLC) plans to raise $503 million at a $2.7 billion market cap. The company serves children from 6 weeks to 12 years of age through 1,480 early childhood education centers and 650 before- and after-school sites across 40 states and Washington DC. While KinderCare is a leader in the early childhood education market, its business been significantly disrupted by the pandemic.\nBraze(BRZE) plans to raise $460 million at a $5.9 billion market cap. Founder-led Braze provides a customer engagement platform used by businesses to improve their marketing. Unprofitable with strong growth, Braze serves over 1,100 clients with net revenue retention of 120%+ as of 7/31/21.\nFast casual salad chain Sweetgreen(SG) plans to raise $300 million at a $2.9 billion market cap. Sweetgreen owned and operated 140 restaurants in 13 states and Washington DC as of 9/26/21. The company has a strong digital presence and plans double its store count in the next three to five years, though it has yet to achieve profitability.\nUserTesting(USER) plans to raise $227 million at a $2.6 billion market cap. The company provides a video-first customer feedback platform for enterprises, providing richer, more contextualized insights by capturing various human signals. Its customers include a diverse base of more than 2,100 enterprises, with strong net dollar-based retention. However, it remains unprofitable due to high S&M spend.\nAustralia’s Iris Energy(IREN), a Bitcoin mining company primarily powered by renewable energy, plans to raise $215 million at a $1.4 billion market cap. Iris acquired its first site in British Columbia in January 2021, which has approximately 30 MW of capacity and operating hashrate capacity of 0.7EH/s. The company is dependent on the Bitcoin market, and while prices have risen near all-time highs, it remains highly volatile.\nGermany-based Sono Group(SEV) plans to raise $150 million at a $1.1 billion market cap. The company is developing what it believes is disruptive solar technology, as well as a solar and battery powered vehicle. Despite already accepting 16,000 pre-orders worth $390 million in net sales, it is not expected to reach commercialization until 2023, and will remain highly unprofitable for years.\nCanadian gold exploration company Austin Gold(AUST) plans to raise $15 million at a $64 million market cap. The company currently has interests in four gold exploration properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.\n\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/11/2021, the Renaissance IPO Index was up 3.6% year-to-date, while the S&P 500 was up 23.8%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Uber Technologies (UBER). The Renaissance International IPO Index was down 18.7% year-to-date, while the ACWX was up 8.7%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,"BRZE":0.9,".DJI":0.9,"SG":0.9,"USER":0.9,"IREN":0.9,"KLC":0.9,"AUST.AU":0.9,"SEV":0.9}},"isVote":1,"tweetType":1,"viewCount":2379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844643516,"gmtCreate":1636424942931,"gmtModify":1636425017805,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>I Wana be alone now… need much to ave down .","listText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>I Wana be alone now… need much to ave down .","text":"$Phunware, Inc.(PHUN)$I Wana be alone now… need much to ave down .","images":[{"img":"https://static.tigerbbs.com/8f478d634b92b39c0756aa7813b3a36b","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844643516","isVote":1,"tweetType":1,"viewCount":1561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845914864,"gmtCreate":1636263702957,"gmtModify":1636263703139,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>等你等到我心痛","listText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>等你等到我心痛","text":"$Phunware, Inc.(PHUN)$等你等到我心痛","images":[{"img":"https://static.tigerbbs.com/56fb021ff28dfa2b2e987c78137d49e4","width":"1125","height":"4033"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845914864","isVote":1,"tweetType":1,"viewCount":1520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842876607,"gmtCreate":1636165566615,"gmtModify":1636165566782,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>欲哭无泪","listText":"<a href=\"https://laohu8.com/S/PHUN\">$Phunware, Inc.(PHUN)$</a>欲哭无泪","text":"$Phunware, Inc.(PHUN)$欲哭无泪","images":[{"img":"https://static.tigerbbs.com/78ea4fc20982331c2ade2aa4b7c873cc","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842876607","isVote":1,"tweetType":1,"viewCount":3126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842878745,"gmtCreate":1636165528874,"gmtModify":1636165529094,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>遥不可及吗？","listText":"<a href=\"https://laohu8.com/S/ATER\">$Aterian Inc.(ATER)$</a>遥不可及吗？","text":"$Aterian Inc.(ATER)$遥不可及吗？","images":[{"img":"https://static.tigerbbs.com/7182312814262af3999baf0490b64a0c","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842878745","isVote":1,"tweetType":1,"viewCount":1564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842852154,"gmtCreate":1636164391894,"gmtModify":1636164392109,"author":{"id":"3580183572660250","authorId":"3580183572660250","name":"Vincxie","avatar":"https://static.tigerbbs.com/638af725e5e95ef7d2e629a3a49b0690","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580183572660250","idStr":"3580183572660250"},"themes":[],"htmlText":"Ok ","listText":"Ok ","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842852154","repostId":"1152406340","repostType":2,"repost":{"id":"1152406340","kind":"news","pubTimestamp":1636157546,"share":"https://www.laohu8.com/m/news/1152406340?lang=zh_CN&edition=full","pubTime":"2021-11-06 08:12","market":"us","language":"en","title":"Will Pfizer Outgun Merck With Oral COVID-19 Pill?<blockquote>辉瑞口服新冠肺炎药丸会超过默克吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1152406340","media":"Benzinga","summary":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy ","content":"<p><div> Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market. The stakes are high, with an effective treatment for the disease ...</p><p><blockquote><div>默克公司正在与同行辉瑞公司展开新冠肺炎治疗市场的争夺战。风险很高，这种疾病的有效治疗方法...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Pfizer Outgun Merck With Oral COVID-19 Pill?<blockquote>辉瑞口服新冠肺炎药丸会超过默克吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Pfizer Outgun Merck With Oral COVID-19 Pill?<blockquote>辉瑞口服新冠肺炎药丸会超过默克吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-06 08:12</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market. The stakes are high, with an effective treatment for the disease ...</p><p><blockquote><div>默克公司正在与同行辉瑞公司展开新冠肺炎治疗市场的争夺战。风险很高，这种疾病的有效治疗方法...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞"},"source_url":"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152406340","content_text":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.\nPfizer Dips Into COVID-19 Treatment Arena:After acing the COVID-19 vaccine race along with its German partner BioNTech SE, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.\nThe company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.\nThe positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.\nMerck had its share of upside in early October when it reported positive Phase 3 data for an oral COVID-19 pill, molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.\nThese two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.\nPfizer Vs. Merck Data Comparison:As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.\nOnly about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.\nSimilar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.\nMerck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.\nThrough day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight deaths in patients who received placebo.\nNot only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.\n\"Between Roche Holding AG's recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.\nAuthorization Before Year-End?At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.\nIt plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.\nBofA expects the application to be soon submitted to the FDA, with an authorization likely by the end of the year.\nMeanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.\nIts application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.\nThe commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.\nMeanwhile, Gilead, Inc.'s antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.","news_type":1,"symbols_score_info":{"MRK":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}